Status:
COMPLETED
A Retrospective Review of Malignant Liver Tumors
Lead Sponsor:
University of Oklahoma
Conditions:
Liver Cancer
Eligibility:
All Genders
20-90 years
Brief Summary
This study will review the treatment and outcomes of patients having primary and metastatic hepatic malignancies. Patients treated with surgical resection, percutaneous radiofrequency ablation (RFA), ...
Detailed Description
Subjects will be identified by diagnosis and procedure codes from a university surgical practice and the St. John Medical Center Cancer Registry. Data will be obtained by review of both the clinic and...
Eligibility Criteria
Inclusion
- Patients with primary or metastatic hepatic malignancies
Exclusion
- Patients not diagnosed with primary or metastatic hepatic malignancies
Key Trial Info
Start Date :
October 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2011
Estimated Enrollment :
228 Patients enrolled
Trial Details
Trial ID
NCT00728650
Start Date
October 1 2003
End Date
June 1 2011
Last Update
February 7 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Oklahoma College of Medicine, Tulsa - Department of Surgery
Tulsa, Oklahoma, United States, 74135